biglycan
| GO Term | Evidence Code | PMID |
|---|---|---|
| blood vessel remodeling |
|
|
| bone development |
|
|
| articular cartilage development |
|
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| Golgi lumen |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular matrix structural constituent |
|
|
| protein binding |
|
|
| glycosaminoglycan binding |
|
|
| cytokine binding |
|
|
| extracellular matrix structural constituent conferring compression resistance |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0112150 | X-linked spondyloepimetaphyseal dysplasia | |
| DOID:0111861 | Meester-Loeys syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026